Nhat Duong

ORCID: 0000-0003-2852-4263
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Automotive and Human Injury Biomechanics
  • Medical Imaging Techniques and Applications
  • Cancer Genomics and Diagnostics
  • Genomics and Rare Diseases
  • Biomedical Text Mining and Ontologies
  • SARS-CoV-2 and COVID-19 Research
  • RNA modifications and cancer
  • Genomic variations and chromosomal abnormalities
  • Traffic and Road Safety
  • Epigenetics and DNA Methylation
  • Respiratory viral infections research
  • Pancreatic and Hepatic Oncology Research
  • Transportation Safety and Impact Analysis
  • Space Exploration and Technology
  • Animal Virus Infections Studies
  • Genetic Associations and Epidemiology
  • Human-Automation Interaction and Safety

National Hospital
2021-2024

Children's Hospital of Philadelphia
2018-2023

National Center for Injury Prevention and Control
2018

Drexel University
2018

Pediatric brain and spinal cancers are collectively the leading disease-related cause of death in children; thus, we urgently need curative therapeutic strategies for these tumors. To accelerate such discoveries, Children's Brain Tumor Network (CBTN) Pacific Neuro-Oncology Consortium (PNOC) created a systematic process tumor biobanking, model generation, sequencing with immediate access to harmonized data. We leverage data establish OpenPBTA, an open collaborative project over 40 scalable...

10.1016/j.xgen.2023.100340 article EN cc-by Cell Genomics 2023-05-31

Summary Pediatric brain and spinal cancer are the leading disease-related cause of death in children, thus we urgently need curative therapeutic strategies for these tumors. To accelerate such discoveries, Children’s Brain Tumor Network Pacific Neuro-Oncology Consortium created a systematic process tumor biobanking, model generation, sequencing with immediate access to harmonized data. We leverage data create OpenPBTA, an open collaborative project which establishes over 40 scalable analysis...

10.1101/2022.09.13.507832 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2022-09-16

ABSTRACT The SARS-CoV-2 virus has emerged as a global pandemic, severely impacting everyday life. Significant resources have been dedicated towards profiling the viral genome in adult population. We present an analysis of genomes acquired from pediatric patients presenting to Children’s National Hospital Washington D.C, including 24 with primary SARS CoV2 infection and 3 Multisystem Inflammatory Syndrome Children (MIS-C) undergoing treatment at our facility. Viral using next generation...

10.1101/2021.02.08.21251344 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2021-02-10

Objective: Booster seats ensure appropriate belt fit for children that a traditional vehicle seat cannot offer to small occupants. In this study, the responses of PIPER 6-year-old human body model are compared Q6 anthropomorphic test dummy (ATD).Methods: Eight frontal impact finite element simulations were run using 4 different child restraining systems on FMVSS 213 bench. Kinematics and kinetics extracted between 2 models.Results: The showed variation by 11.2 ± 14.1% (head resultant...

10.1080/15389588.2018.1532204 article EN Traffic Injury Prevention 2018-12-28

Developmental delays are common in pediatric patients, but clinical features predictive of genetic vs idiopathic neurodevelopmental disorders unclear. First presentation rare (RGNDs) often nonspecific, which leads to diagnosis. RGNDs represent a large percentage diseases can present initially during developmental screening the primary care setting. This project aimed elucidate relationship between outcomes and eventual evaluation.

10.1016/j.gimo.2024.101101 article EN cc-by-nc-nd Genetics in Medicine Open 2024-01-01

Abstract Pediatric brain tumors comprise a heterogeneous molecular and histological landscape that challenges most current precision-medicine approaches. While recent large-scale efforts to molecularly characterize distinct entities have dramatically advanced the field’s capacity classify further define subtypes, developing therapeutic less toxic molecularly-defined clinical approaches remains challenge. To new meet these advance scalable, shared biospecimen- data-resources for pediatric...

10.1093/neuonc/noab090.161 article EN cc-by-nc Neuro-Oncology 2021-06-01
Coming Soon ...